Antifungal activity assay
As shown in Fig. 1, HT11 had a good inhibitory effect against the fungus Botrytis fabiopsis, with an inhibitory rate of 81.08%.
Comparative genomic analysis
The isolated bacterial strain HT11 was closely related to Pseudomonas sp. LBUM920 (GCF_003852315.1), with an 16S rRNA gene sequence similarity of 99.93% (Fig. 2). Furthermore, the ANI value was highest for Pseudomonas sp. LBUM920 (96.55%). These results suggest that the HT11 strain belonged to the genus Pseudomonas.
Genome features
Pseudomonas sp. HT11 only had a single circular chromosome (Fig. 3a) and no plasmids. The circular genome was 6,335,588 bp in length, with a G+C content of 60.61%. It encoded 5,366 predicted open reading frames (ORFs), 66 tRNA genes, and 16 rRNA genes (5 16S rRNA genes, 5 23S rRNA genes, and 6 5S rRNA genes). The complete genome contained eight gene islands, four prophages, and one CRISPR-Cas system.
Functional prediction
The total length of the annotated genes accounted for 82.93% (5,254,103/6,335,588 bp) of the complete genome. The predicted functional ORFs were grouped into 24 COG categories. These categories involved storage and processing (A, 1 ORF; J, 282 ORFs; K, 511 ORFs; L, 162 ORFs; R, 449 ORFs; X, 86 ORFs), metabolism (C, 248 ORFs; E, 580 ORFs; F, 120 ORFs; G, 321 ORFs; H,286 ORFs, I, 277 ORFs; P, 317 ORFs; Q, 105 ORFs), cellular processes and signaling (D, 58 ORFs; M, 325 ORFs; N, 97 ORFs; O, 208 ORFs; T, 420 ORFs; U, 130 ORFs; V, 122 ORFs; W, 52 ORFs; Z, 2 ORF), and unknown functions (S, 207 ORFs) (Fig. 3b). Additionally, the predicted functional ORFs were categorized into six KEGG level 1 pathways, comprising cellular processes, environmental information processing, genetic information processing, human diseases, metabolism, and organismal systems (Fig. 4).
Analysis of secondary metabolites
The antiSMASH results indicated that the HT11 genome harbored 14 putative biosynthetic gene clusters (BGCs) that might be responsible for secondary metabolite production. Of these, 11 exhibited similarity to known BGCs (Table 1). In particular, there was a phenazine BGC (shown in row 5 of Table 1) and a non-ribosomal peptide synthase (NRPS) BGC (shown in row 6 of Table 1) that exhibited 100% similarity to a known pyochelin BGC and a known pyocyanin BGC, respectively, from Pseudomonas aeruginosa PAO1 (Mavrodi et al. 2001; Reimmann et al. 2001). Additionally, a putative NRPS BGC (shown in row 4 of Table 1) was 75% similar to a known viscosin BGC from Pseudomonas fluorescens SBW25 (Braun et al .2001). Furthermore, a putative NRPS BGC (shown in row 10 of Table 1) was 70% similar to a known tolaasin I/tolaasin F BGC from Pseudomonas costantinii (Scherlach et al. 2013; Jo et al. 2001; Cho et al. 2007). As the remaining ten putative BGCs exhibited low (5–45%) or no similarity to known BGCs (Table 1), it is likely that Pseudomonas sp. HT11 can synthesize novel natural products. Further study of these putative BGCs and the bioactive compounds synthesized by them will help us to understand the ecological role that Pseudomonas sp. HT11 plays in plants and to develop its applications accordingly.
Table 1 Putative biosynthetic gene clusters (BGCs) in the HT11 genome predicted by antiSMASH
Cluster number
|
Type
|
Similar
cluster
|
MIBiG accession no.
|
Similarity
(%)
|
No. of genes
|
1
|
NRPS-like
|
ambactin
|
BGC0001131
|
25
|
24
|
2
|
arylpolyene
|
APE Vf
|
BGC0000837
|
45
|
37
|
3
|
RiPP-like
|
ND
|
ND
|
-
|
11
|
4
|
NRPS
|
viscosin
|
BGC0001312
|
75
|
32
|
5
|
NRPS
|
pyochelin
|
BGC0000412
|
100
|
33
|
6
|
phenazine
|
pyocyanin
|
BGC0000936
|
100
|
23
|
7
|
thiopeptide
|
lipopolysaccharide
|
BGC0000774
|
5
|
26
|
8
|
NRPS
|
pyoverdin
|
BGC0000413
|
11
|
34
|
9
|
betalactone
|
fengycin
|
BGC0001095
|
13
|
17
|
10
|
NRPS
|
tolaasin I/tolaasin F
|
BGC0000447
|
70
|
33
|
11
|
NAGGN
|
ND
|
ND
|
-
|
9
|
12
|
NRPS
|
pyoverdin
|
BGC0000413
|
10
|
41
|
13
|
redox-cofactor
|
lankacidin C
|
BGC0001100
|
13
|
16
|
14
|
RiPP-like
|
ND
|
ND
|
-
|
9
|
ND, no defined clusters are similar; NAGGN, N-acetylglutaminylglutamine amide; NRPS, non-ribosomal peptide synthase; MIBiG, Minimum Information about a Biosynthetic Gene cluster; RiPP-like, other unspecified ribosomally synthesized and post-transcriptionally modified peptide product.